Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $84,919,510    

Indirect Value

  $13,116,072,593      
Total Shares   142,789,105      
Total Value   $13,200,992,103      


Incyte Corp
 $35,400,861 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $35,400,861 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 41 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGEN Seagen Inc Director   –       •      –    2006-06-09 4 B $4.00 $124,916 I/I 31,197 68,988 2.1 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-10 4 B $7.47 $235,564 I/I 31,538 2,381,777 1.5 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-10-29 4 S $1.18 $37,461 I/I (31,666) 6,666,436 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-06-27 4 S $15.41 $489,899 I/I (31,791) 57,667 0 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-15 4 B $28.88 $927,680 I/I 32,125 7,407,547 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-06-27 4 B $4.03 $130,374 I/I 32,297 1,295,373 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-10-30 4 S $12.03 $388,909 I/I (32,332) 1,330,050 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-05-06 4 S $12.62 $410,982 I/I (32,508) 312,441 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $410,220 I/I 32,630 1,215,554 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-09-29 4 B $17.97 $593,488 I/I 32,995 1,876,525 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2003-10-06 4 B $10.80 $356,940 I/I 33,050 39,732 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-08 4 B $26.17 $868,267 I/I 33,141 1,339,422 2.25 -
INCY Incyte Corp Director   –       •       •   2009-03-02 4/A B $2.14 $71,831 I/I 33,364 7,060,749 2.25 -
INCY Incyte Corp Director   –       •       •   2009-03-02 4 B $2.14 $71,831 I/I 33,364 7,060,749 2.25 -
TPPHQ Tapestry Pharmaceuticals ... 10% Owner   –       –       •   2008-05-28 4 D $0.00 $0 I/I (34,035) 7,085 0 -
SGEN Seagen Inc Director   –       •       •   2006-06-26 4 B $4.00 $136,919 I/I 34,216 1,263,076 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-29 4 B $16.39 $561,850 I/I 34,288 1,145,120 2.25 -
INCY Incyte Corp Director   –       •       •   2010-08-10 4 S $14.00 $482,421 I/I (34,462) 3,330,071 0 -
GHDX Genomic Health Inc Director   –       •       •   2010-09-01 4 B $14.43 $499,331 I/I 34,578 4,925,760 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-10-29 4 S $12.47 $431,430 I/I (34,606) 1,362,382 0 -
INCY Incyte Corp Director   –       •       •   2008-01-14 4 B $10.99 $380,398 I/I 34,621 5,427,653 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-07-14 4 B $3.50 $121,247 I/I 34,642 35,898 1.5 -
SGEN Seagen Inc Director   –       •       •   2006-08-11 4 B $4.03 $139,991 I/I 34,745 1,523,919 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $439,185 I/I 34,934 1,691,130 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2011-02-25 4 B $23.89 $843,196 I/I 35,078 5,093,345 2.25 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41  42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 41 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed